Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | IC50 | = | 1.82E+14 | nM | 12166932 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 3.1 | m equiv kg-1 | 8093626 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 1.8 | m equiv kg-1 | 8093626 |
NPT2 | Others | Unspecified | Ratio | = | 1.7 | 8093626 | ||
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 3.9 | m equiv kg-1 | 8093626 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 1.9 | m equiv kg-1 | 8093626 |
NPT2 | Others | Unspecified | Ratio | = | 2 | 8093626 | ||
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 5.1 | m equiv kg-1 | 8093626 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 2.3 | m equiv kg-1 | 8093626 |
NPT2 | Others | Unspecified | Ratio | = | 2.2 | 8093626 | ||
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 0.261 | 3001305 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 7.17 | ml | 3001305 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Ratio | = | 3 | 7966129 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Ratio | = | 4.3 | 7966129 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Ratio | = | 4.6 | 7966129 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Ratio | = | 5.1 | 7966129 | |
NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Ratio | = | 4.4 | 7966129 | |
NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Ratio | = | 9.6 | 7966129 | |
NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Activity | = | 193 | u equiv min-1 | 6737427 |
NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Activity | = | 27 | u equiv min-1 | 6737427 |
NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Activity | = | 11 | u equiv min-1 | 6737427 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 127 | 6737427 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 133 | 6737427 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 168 | 6737427 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 154 | 6737427 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 50 | 6737427 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 33 | 6737427 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 61 | 6737427 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 146 | 6737427 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 143 | 6737427 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 191 | 6737427 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 163 | 6737427 | |
NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Activity | = | 50 | 6737427 | |
NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Activity | = | 18 | 6737427 | |
NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Activity | = | 7 | 6737427 | |
NPT2 | Others | Unspecified | Ratio | = | -0.02 | 7277396 | ||
NPT1166 | Individual Protein | Angiotensin-converting enzyme | Homo sapiens | ED50 | > | 100 | mg/kg | 2342054 |
NPT2 | Others | Unspecified | Ratio | = | -0.02 | 7277395 | ||
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED50 | = | 4.86 | mg/kg | 1433206 |
NPT604 | Individual Protein | Serum albumin | Homo sapiens | Ki | = | 2.29E+12 | nM | 15801837 |
NPT612 | Individual Protein | Canalicular multispecific organic anion transporter 1 | Homo sapiens | Activity | = | 94 | % | 18457386 |
NPT613 | Individual Protein | Solute carrier family 22 member 1 | Homo sapiens | Inhibition | = | -9.8 | % | 18788725 |
NPT605 | Organism | Homo sapiens | Homo sapiens | Activity | = | 0.69 | % | 20022146 |
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 0.8 | nM | PubChem BioAssay data set |
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 4.5 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 3162.3 | nM | PubChem BioAssay data set | |
NPT93 | Individual Protein | Survival motor neuron protein | Homo sapiens | Potency | = | 1258.9 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 11220.2 | nM | PubChem BioAssay data set | |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Potency | = | 281.8 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 12589.3 | nM | PubChem BioAssay data set | |
NPT1415 | Individual Protein | Heat shock factor protein 1 | Mus musculus | EC50 | > | 195000 | nM | PubChem BioAssay data set |
NPT796 | Individual Protein | Peripheral myelin protein 22 | Homo sapiens | Potency | = | 95283.4 | nM | PubChem BioAssay data set |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 31622.8 | nM | PubChem BioAssay data set | |
NPT212 | Individual Protein | Cytochrome P450 2C9 | Homo sapiens | Potency | = | 31622.8 | nM | PubChem BioAssay data set |
NPT212 | Individual Protein | Cytochrome P450 2C9 | Homo sapiens | Potency | = | 7943.3 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 15848.9 | nM | PubChem BioAssay data set | |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | Ki | = | 328 | nM | 21377369 |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Ki | = | 290 | nM | 21377369 |
NPT2 | Others | Unspecified | Ki | = | 630 | nM | 21377369 | |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | 316.2 | nM | PubChem BioAssay data set | |
NPT62 | Individual Protein | 6-phospho-1-fructokinase | Trypanosoma brucei | Potency | 8492.1 | nM | PubChem BioAssay data set | |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | 39810.7 | nM | PubChem BioAssay data set | |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 32629.4 | nM | PubChem BioAssay data set | |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | Ki | = | 328 | nM | 21757360 |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Ki | = | 290 | nM | 21757360 |
NPT2 | Others | Unspecified | Ki | = | 6810 | nM | 21757360 | |
NPT2 | Others | Unspecified | Ki | = | 6870 | nM | 21757360 | |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | 89125.1 | nM | PubChem BioAssay data set | |
NPT249 | Individual Protein | Glucocorticoid receptor | Homo sapiens | Potency | 50118.7 | nM | PubChem BioAssay data set | |
NPT71 | Cell Line | HEK293 | Homo sapiens | Potency | 7304.8 | nM | PubChem BioAssay data set | |
NPT5280 | Individual Protein | Astrosclerin-3 | Astrosclera willeyana | Ki | = | 394 | nM | 22285172 |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | Ki | = | 328 | nM | 22285172 |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Ki | = | 290 | nM | 22285172 |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT666 | Individual Protein | Solute carrier family 22 member 6 | Rattus norvegicus | Ki | = | 150000 | nM | 10991988 |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 51.7 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Ki | = | 79.5 | nM | 23181552 | |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Ki | = | 290 | nM | 23181552 |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | Ki | = | 328 | nM | 23181552 |
NPT2 | Others | Unspecified | Ki | = | 134 | nM | 23391336 | |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Ki | = | 290 | nM | 23391336 |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | Ki | = | 328 | nM | 23391336 |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | Ki | = | 328 | nM | 22883029 |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Ki | = | 290 | nM | 22883029 |
NPT2 | Others | Unspecified | Ki | = | 7.2 | nM | 22883029 | |
NPT2 | Others | Unspecified | Ki | = | 50.2 | nM | 23977960 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | FC | = | 2 | 24075732 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | FC | = | 3.5 | 24075732 | |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 68.94 | % | 23571415 |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 82.24 | % | 23571415 |
NPT5947 | Individual Protein | Delta carbonic anhydrase | Thalassiosira weissflogii | Ki | = | 4270 | nM | 24314394 |
NPT2 | Others | Unspecified | Ki | = | 380 | nM | 24314394 | |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Ki | = | 290 | nM | 24314394 |
NPT2 | Others | Unspecified | Ki | = | 50.2 | nM | 24314394 | |
NPT2 | Others | Unspecified | Ki | = | 380 | nM | 24316122 | |
NPT2 | Others | Unspecified | Potency | 14950.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 21117.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2713.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 7.8 | nM | PubChem BioAssay data set | ||
NPT104 | Individual Protein | Cerebroside-sulfatase | Homo sapiens | Potency | 151 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 16774.4 | nM | PubChem BioAssay data set | ||
NPT11 | Individual Protein | Guanine nucleotide-binding protein G(s), subunit alpha | Homo sapiens | Potency | 10000 | nM | PubChem BioAssay data set | |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | 3548.1 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 10583.9 | nM | PubChem BioAssay data set | ||
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 12300 | milliequivalent | 660587 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 11200 | milliequivalent | 660587 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 13100 | milliequivalent | 660587 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 12800 | milliequivalent | 660587 |
NPT5688 | Organism | Pan troglodytes | Pan troglodytes | Activity | = | 144 | uEq | 660587 |
NPT5688 | Organism | Pan troglodytes | Pan troglodytes | Ratio | = | -0.02 | 660587 | |
NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Activity | = | 166 | milliequivalent | 660587 |
NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Activity | = | 33 | milliequivalent | 660587 |
NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Activity | = | 156 | milliequivalent | 660587 |
NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Activity | = | 3 | ml | 660587 |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | Ki | = | 328 | nM | 24792813 |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Ki | = | 290 | nM | 24792813 |
NPT2 | Others | Unspecified | Ki | = | 15800 | nM | 24792813 | |
NPT2 | Others | Unspecified | Ki | = | 745 | nM | 24792813 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 131 | 10'2mEq | 915900 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 128 | 10'2mEq | 915900 |
NPT5688 | Organism | Pan troglodytes | Pan troglodytes | Activity | = | 144 | uEq | 915900 |
NPT5688 | Organism | Pan troglodytes | Pan troglodytes | Ratio | = | -0.02 | 915900 | |
NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Activity | = | 166 | uEq | 915900 |
NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Activity | = | 33 | uEq | 915900 |
NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Activity | = | 156 | uEq | 915900 |
NPT1016 | Organism | Canis familiaris | Canis lupus familiaris | Activity | = | 3 | ml | 915900 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 123 | 10'2mEq | 915900 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 112 | 10'2mEq | 915900 |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | Ki | = | 328 | nM | 25129169 |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Ki | = | 290 | nM | 25129169 |
NPT2 | Others | Unspecified | Ki | = | 1572 | nM | 25129169 | |
NPT2 | Others | Unspecified | Ki | = | 380 | nM | 25129169 | |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | Ki | = | 328 | nM | 25533402 |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Ki | = | 290 | nM | 25533402 |
NPT2 | Others | Unspecified | Ki | = | 153 | nM | 25533402 | |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | Ki | = | 328 | nM | 25773015 |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Ki | = | 290 | nM | 25773015 |
NPT2 | Others | Unspecified | Ki | = | 380 | nM | 25773015 | |
NPT2 | Others | Unspecified | Ki | = | 58.7 | nM | 25773015 | |
NPT5948 | Individual Protein | AGAP002992-PA | Anopheles gambiae | Ki | = | 31.5 | nM | 25882523 |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Ki | = | 290 | nM | 25882523 |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | Ki | = | 328 | nM | 25882523 |
NPT2 | Others | Unspecified | Ki | = | 2615 | nM | 25913199 | |
NPT1463 | Individual Protein | Cytochrome P450 2J2 | Homo sapiens | IC50 | > | 50000 | nM | 23033255 |
NPT74 | Individual Protein | Proto-oncogene c-JUN | Homo sapiens | Potency | 60740.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | AC50 | 2818.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 54135.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 30171.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 21861.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 42617.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 1258.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 631 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Ki | = | 790 | nM | 26174556 | |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Ki | = | 290 | nM | 26174556 |
NPT2 | Others | Unspecified | Ki | = | 58.7 | nM | 26174556 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | FC | = | 2.1 | 26191360 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | FC | = | 2.3 | 26191360 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | FC | = | 1.4 | 26191360 | |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | Ki | = | 328 | nM | 26525863 |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Ki | = | 290 | nM | 26525863 |
NPT2 | Others | Unspecified | Ki | = | 630 | nM | 26525863 | |
NPT2 | Others | Unspecified | Ki | = | 866 | nM | 26525863 | |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | Ki | = | 328 | nM | 26691758 |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Ki | = | 290 | nM | 26691758 |
NPT5949 | Individual Protein | Carbonate dehydratase | Sulfurihydrogenibium sp. (strain YO3AOP1) | Ki | = | 7.2 | nM | 26691758 |
NPT5278 | Individual Protein | Carbonic anhydrase, alpha family | Thiomicrospira crunogena (strain XCL-2) | Ki | = | 296 | nM | 26691758 |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Ki | = | 290 | nM | 26850377 |
NPT2 | Others | Unspecified | Ki | = | 79.5 | nM | 26850377 | |
NPT2 | Others | Unspecified | Ki | = | 87 | nM | 26850377 | |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | Ki | = | 328 | nM | 26850377 |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Ki | = | 290 | nM | 26832216 |
NPT2 | Others | Unspecified | Ki | = | 380 | nM | 26832216 | |
NPT2 | Others | Unspecified | Ki | = | 58.7 | nM | 26832216 | |
NPT2 | Others | Unspecified | Ki | = | 790 | nM | 26832216 | |
NPT2 | Others | Unspecified | Ki | = | 345 | nM | 26832216 | |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | Ki | = | 328 | nM | 26920803 |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Ki | = | 290 | nM | 26920803 |
NPT2 | Others | Unspecified | Ki | = | 87 | nM | 26920803 | |
NPT2 | Others | Unspecified | Ki | = | 133 | nM | 26920803 | |
NPT2 | Others | Unspecified | Ki | = | 500 | nM | 26972117 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | FC | = | 2.8 | 27017115 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | FC | = | 2.2 | 27017115 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC321053 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.6639 | Remote Similarity | NPC315403 |
0.6403 | Remote Similarity | NPC125416 |
0.6241 | Remote Similarity | NPC328877 |
0.621 | Remote Similarity | NPC43655 |
0.6111 | Remote Similarity | NPC107135 |
0.6099 | Remote Similarity | NPC218710 |
0.6016 | Remote Similarity | NPC134825 |
0.5781 | Remote Similarity | NPC297532 |
0.5736 | Remote Similarity | NPC240134 |
0.5669 | Remote Similarity | NPC229477 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC321053 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD9282 | Approved |
0.9375 | High Similarity | NPD559 | Approved |
0.9375 | High Similarity | NPD9483 | Approved |
0.9302 | High Similarity | NPD9547 | Approved |
0.9091 | High Similarity | NPD1072 | Approved |
0.8955 | High Similarity | NPD503 | Approved |
0.8633 | High Similarity | NPD1301 | Approved |
0.8511 | High Similarity | NPD1636 | Approved |
0.8346 | Intermediate Similarity | NPD9252 | Approved |
0.8308 | Intermediate Similarity | NPD9499 | Clinical (unspecified phase) |
0.8189 | Intermediate Similarity | NPD9246 | Approved |
0.7609 | Intermediate Similarity | NPD9485 | Approved |
0.7597 | Intermediate Similarity | NPD202 | Clinical (unspecified phase) |
0.7244 | Intermediate Similarity | NPD278 | Approved |
0.7192 | Intermediate Similarity | NPD1590 | Approved |
0.7162 | Intermediate Similarity | NPD1583 | Approved |
0.6994 | Remote Similarity | NPD1513 | Clinical (unspecified phase) |
0.6953 | Remote Similarity | NPD233 | Clinical (unspecified phase) |
0.6918 | Remote Similarity | NPD2032 | Discontinued |
0.6917 | Remote Similarity | NPD1311 | Approved |
0.6835 | Remote Similarity | NPD2449 | Approved |
0.6835 | Remote Similarity | NPD2448 | Approved |
0.6788 | Remote Similarity | NPD9476 | Approved |
0.6765 | Remote Similarity | NPD1312 | Approved |
0.6728 | Remote Similarity | NPD184 | Approved |
0.6718 | Remote Similarity | NPD1824 | Discontinued |
0.6644 | Remote Similarity | NPD2033 | Phase 2 |
0.6641 | Remote Similarity | NPD261 | Approved |
0.6639 | Remote Similarity | NPD9108 | Approved |
0.6617 | Remote Similarity | NPD916 | Discontinued |
0.6597 | Remote Similarity | NPD4015 | Approved |
0.6597 | Remote Similarity | NPD4014 | Approved |
0.6597 | Remote Similarity | NPD4013 | Approved |
0.6566 | Remote Similarity | NPD1226 | Approved |
0.6529 | Remote Similarity | NPD1966 | Approved |
0.6519 | Remote Similarity | NPD526 | Approved |
0.6508 | Remote Similarity | NPD9188 | Approved |
0.6471 | Remote Similarity | NPD560 | Approved |
0.6471 | Remote Similarity | NPD561 | Approved |
0.6429 | Remote Similarity | NPD541 | Approved |
0.6414 | Remote Similarity | NPD572 | Clinical (unspecified phase) |
0.6403 | Remote Similarity | NPD5243 | Approved |
0.6403 | Remote Similarity | NPD5244 | Approved |
0.6403 | Remote Similarity | NPD5245 | Approved |
0.6357 | Remote Similarity | NPD9304 | Approved |
0.6316 | Remote Similarity | NPD4592 | Approved |
0.6299 | Remote Similarity | NPD1938 | Clinical (unspecified phase) |
0.6282 | Remote Similarity | NPD4486 | Approved |
0.6279 | Remote Similarity | NPD9352 | Approved |
0.625 | Remote Similarity | NPD9528 | Approved |
0.625 | Remote Similarity | NPD9527 | Approved |
0.6241 | Remote Similarity | NPD3005 | Phase 3 |
0.6233 | Remote Similarity | NPD3585 | Approved |
0.6233 | Remote Similarity | NPD3584 | Approved |
0.6197 | Remote Similarity | NPD9700 | Clinical (unspecified phase) |
0.6183 | Remote Similarity | NPD9353 | Approved |
0.6154 | Remote Similarity | NPD716 | Approved |
0.6154 | Remote Similarity | NPD759 | Approved |
0.6154 | Remote Similarity | NPD492 | Approved |
0.6139 | Remote Similarity | NPD5621 | Approved |
0.6139 | Remote Similarity | NPD5622 | Approved |
0.6115 | Remote Similarity | NPD461 | Approved |
0.6081 | Remote Similarity | NPD525 | Clinical (unspecified phase) |
0.6067 | Remote Similarity | NPD5268 | Approved |
0.6062 | Remote Similarity | NPD451 | Clinical (unspecified phase) |
0.6056 | Remote Similarity | NPD9720 | Approved |
0.6056 | Remote Similarity | NPD9719 | Approved |
0.6056 | Remote Similarity | NPD1171 | Approved |
0.6039 | Remote Similarity | NPD2399 | Clinical (unspecified phase) |
0.6 | Remote Similarity | NPD1299 | Clinical (unspecified phase) |
0.5987 | Remote Similarity | NPD758 | Approved |
0.5972 | Remote Similarity | NPD726 | Discontinued |
0.5935 | Remote Similarity | NPD2867 | Approved |
0.5899 | Remote Similarity | NPD2522 | Approved |
0.5899 | Remote Similarity | NPD2520 | Approved |
0.589 | Remote Similarity | NPD428 | Approved |
0.589 | Remote Similarity | NPD426 | Approved |
0.589 | Remote Similarity | NPD427 | Approved |
0.589 | Remote Similarity | NPD162 | Approved |
0.5859 | Remote Similarity | NPD9077 | Approved |
0.5848 | Remote Similarity | NPD4532 | Approved |
0.5816 | Remote Similarity | NPD3036 | Approved |
0.5816 | Remote Similarity | NPD2519 | Approved |
0.5816 | Remote Similarity | NPD3009 | Approved |
0.5816 | Remote Similarity | NPD3566 | Approved |
0.5816 | Remote Similarity | NPD3565 | Approved |
0.5816 | Remote Similarity | NPD2518 | Approved |
0.5816 | Remote Similarity | NPD3010 | Approved |
0.5816 | Remote Similarity | NPD2521 | Approved |
0.58 | Remote Similarity | NPD4609 | Approved |
0.58 | Remote Similarity | NPD4608 | Approved |
0.5783 | Remote Similarity | NPD491 | Approved |
0.5753 | Remote Similarity | NPD1094 | Approved |
0.5733 | Remote Similarity | NPD2940 | Approved |
0.5733 | Remote Similarity | NPD2938 | Approved |
0.5714 | Remote Similarity | NPD234 | Approved |
0.5698 | Remote Similarity | NPD3850 | Clinical (unspecified phase) |
0.5694 | Remote Similarity | NPD4085 | Approved |
0.5686 | Remote Similarity | NPD3011 | Approved |
0.5686 | Remote Similarity | NPD3008 | Approved |
0.5686 | Remote Similarity | NPD3012 | Approved |
0.5677 | Remote Similarity | NPD988 | Discontinued |
0.5677 | Remote Similarity | NPD235 | Discontinued |
0.5674 | Remote Similarity | NPD937 | Clinical (unspecified phase) |
0.5668 | Remote Similarity | NPD693 | Phase 3 |
0.5667 | Remote Similarity | NPD2964 | Clinical (unspecified phase) |
0.5655 | Remote Similarity | NPD2925 | Approved |
0.5655 | Remote Similarity | NPD2924 | Approved |
0.5641 | Remote Similarity | NPD3652 | Approved |
0.5632 | Remote Similarity | NPD5921 | Clinical (unspecified phase) |
0.5625 | Remote Similarity | NPD452 | Phase 1 |
0.5625 | Remote Similarity | NPD453 | Phase 1 |
0.5622 | Remote Similarity | NPD2394 | Phase 2 |
0.5621 | Remote Similarity | NPD6574 | Clinical (unspecified phase) |
0.5616 | Remote Similarity | NPD3483 | Approved |
0.5616 | Remote Similarity | NPD3484 | Approved |
0.5613 | Remote Similarity | NPD5782 | Phase 3 |
0.5605 | Remote Similarity | NPD5431 | Phase 2 |
Molecular Weight:   | 296.96 |
ALogP:   | -1.5436 |
MLogP:   | 1.13 |
XLogP:   | -1.263 |
# Rotatable Bonds:   | 3 |
Polar Surface Area:   | 135.12 |
# H-Bond Aceptor:   | 7 |
# H-Bond Donor:   | 3 |
# Rings:   | 2 |
# Heavy Atoms:   | 17 |